Accession Number: | 0001209191-20-031538 |
Date: | 2020-05-19 |
Issuer: | ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) |
Original Submission Date: |
DOBMEIER ERIC
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
SUITE 200
SEATTLE, WA 98102
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-19 | M | 5,000 | a | $6.32 | 5,000 | direct | ||
COMMON STOCK | 2020-05-19 | S | 5,000 | d | $40.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.32 | 2020-05-19 | deemed execution date | M | 5,000 (d) | 2026-10-18 | common stock 5,000 | $6.32 | 70,000 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 25, 2019. |
f2 | the options vested with respect to 1/4 of the reporting person's shares on september 28, 2017, with an additional 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |